Lumigan combined with Xalatan

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Tremor Other Serious 1/1/2004 72 Female 125 lb 1/19/2006 United States
Primary
Secondary
Concomitant
Paraesthesia Other Serious 1/1/2004 72 Female 125 lb 2/9/2006 Physician United States
Primary
Secondary
Concomitant
Hypertension Other Serious 12/1/2005 74 Male 2/27/2006 Physician Spain
Primary
Concomitant
Uveitis Other Serious 4/1/2005 72 Female 132 lb 3/1/2006 Physician France
Primary
Concomitant
Trichiasis Other Serious 85 Female 100 lb 3/21/2006 United States
Primary
Concomitant
Therapy Non-responder Other Serious 4/1/2005 72 Female 132 lb 4/7/2006 Physician France
Primary
Secondary
Unevaluable Event Other Serious 85 Female 100 lb 4/25/2006 Physician United States
Primary
Concomitant
Visual Acuity Reduced Other Serious Female 140 lb 6/5/2006 United States
Primary
Secondary
Concomitant
Death Death 4/1/2006 85 Male 6/19/2006 Physician Australia
Primary
Secondary
Iritis Required Intervention 2/1/2006 50 Male 200 lb 7/1/2006 Pharmacist United States
Primary
Secondary
Visual Field Defect Other Serious 12/1/2000 Female 140 lb 9/1/2006 Physician United States
Primary
Secondary
Concomitant
Therapeutic Product Contamination Other Serious 12/1/2000 Female 140 lb 9/1/2006 Physician United States
Primary
Secondary
Concomitant
Visual Field Defect Other Serious 1/1/2004 Male 190 lb 5/15/2007 Consumer United States
Primary
Secondary
Concomitant
Ventricular Hypokinesia Hospitalization 11/7/2006 58 Female 112 lb 7/21/2007 Physician United States
Primary
Concomitant
Ventricular Hypokinesia Hospitalization 11/7/2006 58 Female 112 lb 7/28/2007 Physician United States
Primary
Concomitant
Vomiting Hospitalization 6/1/2007 88 Female 8/24/2007 Physician United States
Primary
Concomitant
Toxic Skin Eruption Other Serious 1/1/2005 Male 8/30/2007 Physician France
Primary
Secondary
Stress Other Serious 1/1/2007 Female 115 lb 9/4/2007 Consumer United States
Primary
Concomitant
Trabeculectomy Other Serious 5/11/2006 Female 155 lb 10/22/2007 Consumer United States
Primary
Concomitant
Rash Other Serious 10/23/2006 64 Female 10/26/2007 Physician Canada
Primary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 11/19/2007 Lawyer United States
Primary
Concomitant
Eye Infection Other Serious 1/1/2001 Female 11/20/2007 Brazil
Primary
Secondary
Toxic Skin Eruption Other Serious 1/1/2005 Male 198 lb 11/26/2007 Physician France
Primary
Secondary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 11/28/2007 Lawyer United States
Primary
Concomitant
Palpitations Other Serious 10/28/2007 Female 154 lb 11/28/2007 Physician United Kingdom
Primary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 12/3/2007 Lawyer United States
Primary
Concomitant
Rash Other Serious 10/23/2006 65 Female 12/5/2007 Physician Canada
Primary
Concomitant
Eye Infection Other Serious 1/1/2001 Female 12/19/2007 Brazil
Primary
Secondary
Iritic Melanoma Other Serious 1/7/2004 Female 12/20/2007 Physician United States
Primary
Secondary
Concomitant
Pruritus Other Serious 1/1/2007 Male 160 lb 12/26/2007 Physician
Primary
Secondary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 12/28/2007 Lawyer United States
Primary
Concomitant
Intraocular Pressure Increased Other Serious 1/1/2007 Female 12/28/2007 Physician France
Primary
Secondary
Labyrinthitis Other Serious 1/1/2001 Female 12/31/2007 Brazil
Primary
Secondary
Concomitant
Overdose Other Serious 1/1/2007 Female 135 lb 2/5/2008 Consumer United States
Primary
Secondary
Concomitant
Heart Disease Congenital Congenital Anomaly 1/1/2007 3/25/2008 Physician France
Primary
Secondary
Vitreous Floaters Other Serious 1/1/2004 Male 190 lb 4/2/2008 Physician United States
Primary
Concomitant
Pelvic Fracture Hospitalization 4/6/2008 Female 124 lb 6/19/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Pelvic Fracture Hospitalization 4/6/2008 Female 124 lb 7/2/2008 Physician United States
Primary
Secondary
Concomitant
Overdose Other Serious 1/1/2007 Female 135 lb 7/25/2008 Consumer United States
Primary
Secondary
Concomitant
Wheezing 6/17/2008 73 Female 8/5/2008 Consumer United States
Primary
Concomitant
Vision Blurred Disability 8/1/2008 Male 224 lb 8/8/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Vision Blurred Disability 8/1/2008 Male 224 lb 8/15/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Wheezing 6/17/2008 73 Female 8/26/2008 Consumer United States
Primary
Concomitant
Vision Blurred Disability 8/1/2008 65 Male 8/22/2008 Physician United States
Primary
Secondary
Concomitant
Vision Blurred Disability 8/1/2008 Male 224 lb 9/2/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Ocular Hyperaemia Other Serious Female 110 lb 9/3/2008 Physician United States
Primary
Secondary
Libido Decreased Other Serious 53 Male 9/12/2008 Consumer Canada
Primary
Secondary
Rash Disability 8/1/2008 65 Male 9/9/2008 Other Health Professional United States
Primary
Concomitant
Ocular Hyperaemia Other Serious Female 110 lb 10/2/2008 Physician United States
Primary
Secondary
Ocular Hyperaemia Other Serious 1/1/2005 Female 105 lb 11/12/2008 Physician United States
Primary
Secondary
Vision Blurred Disability 8/1/2008 Male 224 lb 11/17/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Parkinson's Disease Other Serious 1/1/2005 Female 105 lb 11/25/2008 Physician United States
Primary
Secondary
Vision Blurred Disability 8/1/2008 65 Male 224 lb 11/25/2008 Physician United States
Primary
Secondary
Concomitant
Postnasal Drip Other Serious 9/1/2008 Female 140 lb 1/15/2009 Consumer United States
Primary
Secondary
Concomitant
Treatment Noncompliance Other Serious 5/11/2006 Female 155 lb 3/3/2009 Consumer United States
Primary
Concomitant
Tremor Disability 8/25/2008 Female 126 lb 3/5/2009 Other Health Professional United States
Primary
Concomitant
Libido Decreased Other Serious 53 Male 3/13/2009 Consumer Canada
Primary
Secondary
Pulmonary Hypertension Hospitalization 12/1/2006 79 Female 170 lb 3/16/2009 Consumer United States
Primary
Secondary
Concomitant
Growth Of Eyelashes Other Serious Female 4/27/2009 Consumer United States
Primary
Secondary
Sedation Other Serious 3/27/2009 Female 5/1/2009 Consumer United States
Primary
Secondary
Tongue Dry Other Serious Female 144 lb 5/4/2009 Consumer United States
Primary
Secondary
Cardiac Disorder Other Serious 73 Female 5/21/2009 Consumer Italy
Primary
Secondary
Concomitant
Tongue Dry Other Serious Female 144 lb 5/19/2009 Other Health Professional United States
Primary
Secondary
Sedation Other Serious 3/27/2009 Female 5/29/2009 Consumer United States
Primary
Secondary
Basal Cell Carcinoma Other Serious Male 6/8/2009 Consumer Australia
Primary
Concomitant
Tongue Dry Other Serious Female 144 lb 6/9/2009 Other Health Professional United States
Primary
Secondary
Basal Cell Carcinoma Other Serious Male 7/1/2009 Physician Australia
Primary
Concomitant
Surgery Other Serious 56 Female 7/14/2009 United States
Primary
Concomitant
Vomiting Other Serious 3/18/2008 56 Female 258 lb 7/22/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 3/18/2008 56 Female 258 lb 8/6/2009 Lawyer United States
Primary
Concomitant
Pelvic Fracture Hospitalization 4/6/2008 93 Female 124 lb 8/13/2009 Other Health Professional United States
Primary
Secondary
Concomitant
Vision Blurred Other Serious 4/23/2007 54 Female 258 lb 8/12/2009 United States
Primary
Concomitant
Tremor Other Serious 56 Female 8/14/2009 United States
Primary
Concomitant
Optic Ischaemic Neuropathy Other Serious Male 8/21/2009 Lawyer United States
Primary
Concomitant
Tremor Other Serious 56 Female 8/23/2009 United States
Primary
Concomitant
Thyroxine Free Increased Other Serious 4/23/2007 54 Female 258 lb 9/2/2009 Lawyer United States
Primary
Concomitant
Weight Increased Other Serious 4/23/2007 54 Female 258 lb 9/3/2009 United States
Primary
Concomitant
Urinary Tract Infection Other Serious 4/23/2007 54 Female 258 lb 9/24/2009 United States
Primary
Concomitant
Tremor Other Serious 56 Female 10/10/2009 United States
Primary
Concomitant
Tremor Other Serious 56 Female 10/26/2009 United States
Primary
Concomitant
Prostate Cancer Other Serious 1/1/2009 65 Male 190 lb 11/20/2009 Consumer United States
Primary
Secondary
Concomitant
Syncope Other Serious 7/1/2005 73 Female 11/28/2009 Consumer Italy
Primary
Secondary
Concomitant
Weight Increased Hospitalization 4/23/2007 54 Female 258 lb 11/18/2009 United States
Primary
Concomitant
Prostate Cancer Other Serious 1/1/2009 Male 190 lb 1/4/2010 Physician United States
Primary
Secondary
Concomitant
Nephrolithiasis Other Serious 5/1/2007 Male 202 lb 1/22/2010 Physician United States
Primary
Concomitant
Malignant Neoplasm Progression Death 1/1/2008 Female 95 lb 2/1/2010 Other Health Professional United States
Primary
Concomitant
Eye Operation 2/12/2010 Consumer United States
Primary
Secondary
Nephrolithiasis Other Serious 5/1/2007 79 Male 202 lb 3/3/2010 Physician United States
Primary
Concomitant
Hypertension Other Serious 76 Female 112 lb 4/30/2010 Germany
Primary
Secondary
Concomitant
Thyroid Cancer Other Serious 1/13/2009 71 Female 154 lb 5/6/2010 Consumer United States
Primary
Secondary
Concomitant
Thyroid Cancer Other Serious 71 Female 153 lb 5/10/2010 Consumer United States
Primary
Secondary
Concomitant
Thyroid Cancer Other Serious 1/13/2009 71 Female 137 lb 6/7/2010 Consumer United States
Primary
Secondary
Concomitant
Thyroid Cancer Other Serious 71 Female 153 lb 6/10/2010 Consumer United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Hospitalization 10/19/2009 79 Male 141 lb 6/2/2010 United States
Primary
Secondary
Concomitant
Parkinson's Disease 1/1/2008 62 Female 108 lb 6/23/2010 Other Health Professional United States
Primary
Secondary
Eye Irritation 7/1/2008 56 Female 125 lb 6/24/2010 Consumer United States
Primary
Secondary
Concomitant
Medication Error Female 6/28/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Visual Impairment Male 163 lb 6/28/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Sneezing 9/1/2006 77 Female 220 lb 6/28/2010 Consumer United States
Primary
Secondary
Concomitant
Incorrect Dose Administered 62 Female 7/11/2010 Consumer United States
Primary
Concomitant
Ophthalmological Examination Abnormal Other Serious 63 Male 8/4/2010 Consumer Czech Republic
Primary
Secondary
Thyroid Cancer Other Serious 1/13/2009 71 Female 137 lb 8/5/2010 Physician United States
Primary
Secondary
Concomitant
Thyroid Cancer Other Serious 1/13/2009 71 Female 137 lb 8/20/2010 Physician United States
Primary
Secondary
Concomitant
Wheezing Other Serious 10/1/2003 83 Female 226 lb 8/20/2010 United States
Primary
Secondary
Concomitant
Wheezing Other Serious 10/1/2003 83 Female 226 lb 8/27/2010 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 9/1/2010 Female 163 lb 9/20/2010 Consumer Brazil
Primary
Secondary
Concomitant
Wheezing Other Serious 10/1/2003 83 Female 226 lb 10/21/2010 United States
Primary
Secondary
Concomitant
Pruritus Other Serious Female 10/21/2010 Physician United States
Primary
Secondary
Ocular Hyperaemia Female 10/29/2010 Consumer United States
Primary
Concomitant
Wheezing Other Serious 10/1/2003 83 Female 226 lb 11/8/2010 United States
Primary
Secondary
Concomitant
Dizziness 1/7/2010 82 Male 172 lb 11/29/2010 Consumer United States
Primary
Concomitant
Ocular Hyperaemia Female 1/28/2011 Consumer United States
Primary
Concomitant
Snoring Hospitalization 10/1/2003 83 Female 226 lb 1/31/2011 Other Health Professional United States
Primary
Secondary
Concomitant
Somnolence Other Serious 10/1/2003 83 Female 226 lb 2/10/2011 United States
Primary
Secondary
Concomitant
Skin Discolouration 1/1/2009 70 Female 98 lb 2/16/2011 Consumer United States
Primary
Secondary
Concomitant
Cough 2/1/2010 64 Female 145 lb 2/17/2011 Consumer United States
Primary
Secondary
Concomitant
Headache Female 2/17/2011 Consumer United States
Primary
Secondary
Drug Ineffective Male 2/22/2011 Consumer United States
Primary
Secondary
Cardiac Pacemaker Insertion Hospitalization 2/24/2011 70 Female 3/17/2011 Physician Spain
Primary
Concomitant
Drug Ineffective Other Serious 1/1/2008 53 Female 130 lb 3/22/2011 Consumer United States
Primary
Secondary
Concomitant
Blood Urea Increased Other Serious 10/1/2003 83 Female 226 lb 3/29/2011 Physician United States
Primary
Secondary
Concomitant
Back Pain Disability 10/1/2009 68 Male 235 lb 3/30/2011 Consumer United States
Primary
Secondary
Concomitant
Atrial Fibrillation Hospitalization 79 Female 170 lb 4/7/2011 Lawyer United States
Primary
Secondary
Concomitant
Abasia Other Serious 10/1/2009 70 Male 235 lb 4/11/2011 Consumer United States
Primary
Secondary
Concomitant
Myalgia Other Serious 1/1/2009 69 Male 236 lb 4/11/2011 Consumer United States
Primary
Secondary
Concomitant
Nausea Disability 10/1/2009 69 Male 235 lb 4/14/2011 Consumer United States
Primary
Secondary
Concomitant
Skin Irritation Disability 10/1/2009 68 Male 235 lb 4/13/2011 Consumer United States
Primary
Concomitant
Vomiting Disability 10/1/2009 70 Male 235 lb 4/18/2011 Consumer United States
Primary
Secondary
Concomitant
Asthenia Other Serious 10/1/2009 70 Male 235 lb 4/7/2011 United States
Primary
Secondary
Concomitant
Drug Ineffective Other Serious 1/1/2008 53 Female 130 lb 4/29/2011 Physician United States
Primary
Secondary
Concomitant
Oedema Mouth Other Serious Female 6/29/2011 Consumer United States
Primary
Secondary
Haemorrhage Other Serious 1/23/2011 77 Female 170 lb 6/29/2011 Consumer United States
Primary
Secondary
Concomitant
Oedema Mouth Other Serious Female 6/30/2011 Consumer United States
Primary
Secondary
Eye Swelling Other Serious 83 Female 7/8/2011 Physician United States
Primary
Concomitant
Pharyngeal Oedema Other Serious Female 7/13/2011 Consumer United States
Primary
Secondary
Ocular Hyperaemia Other Serious 83 Female 7/14/2011 Physician United States
Primary
Concomitant
Vitamin B12 Decreased 4/1/2011 72 Female 131 lb 7/19/2011 Consumer United States
Primary
Secondary
Concomitant
Pharyngeal Oedema Other Serious Female 7/25/2011 Consumer United States
Primary
Secondary
Visual Impairment Other Serious 5/9/2003 69 Female 170 lb 7/24/2011 Consumer United States
Primary
Secondary
Concomitant
Eye Disorder Other Serious 1/2/2011 77 Female 170 lb 7/19/2011 Consumer United States
Primary
Secondary
Concomitant
Intraocular Lens Implant Other Serious 9/1/2002 Female 7/28/2011 Consumer Canada
Primary
Concomitant
Eyelid Ptosis Other Serious 77 Female 170 lb 7/29/2011 Consumer United States
Primary
Secondary
Concomitant
Rash Erythematous Other Serious Female 100 lb 8/2/2011 Consumer United States
Primary
Secondary
Concomitant
Vitamin B12 Decreased 4/1/2011 72 Female 131 lb 8/4/2011 Consumer United States
Primary
Secondary
Concomitant
Nausea Other Serious Female 100 lb 8/10/2011 Consumer United States
Primary
Secondary
Concomitant
Lacrimation Increased Other Serious 83 Female 8/12/2011 Physician United States
Primary
Concomitant
Eye Irritation Other Serious 83 Female 8/31/2011 Consumer United States
Primary
Concomitant
Dementia Alzheimer's Type Other Serious 9/2/2011 84 Female 9/16/2011 Consumer United States
Primary
Secondary
Dementia Other Serious 9/2/2011 84 Female 11/15/2011 Consumer United States
Primary
Secondary
Periarthritis Other Serious 1/1/2006 49 Female 204 lb 11/29/2011 Lawyer United States
Primary
Secondary
Concomitant

Drug Data